Title of article
Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings
Author/Authors
Tanabe، نويسنده , , Kengo and Hoye، نويسنده , , Angela and Lemos، نويسنده , , Pedro A and Aoki، نويسنده , , Jiro and Arampatzis، نويسنده , , Chourmouzios A and Saia، نويسنده , , Francesco and Lee، نويسنده , , Chi-hang and Degertekin، نويسنده , , Muzzafer and Hofma، نويسنده , , Sjoerd J and Sianos، نويسنده , , Georgios and McFadden، نويسنده , , Eugene and Smits، نويسنده , , Pieter C and van der Gi، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
4
From page
115
To page
118
Abstract
The percutaneous treatment of coronary bifurcation stenoses is hampered by an increased rate of subsequent restenosis. The present study reports on the outcomes of a consecutive series of 58 patients with 65 de novo bifurcation stenoses treated with sirolimus-eluting stent implantation in both the main vessel and side branch. At 6 months, the incidence of major adverse cardiac events was 10.3% (1 death and 5 target lesion revascularizations) with no episodes of acute myocardial infarction or stent thrombosis.
Journal title
American Journal of Cardiology
Serial Year
2004
Journal title
American Journal of Cardiology
Record number
1897735
Link To Document